We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A list of authorised orphan medicinal products registered by the UK licensing authority.
International leaders will gather to address some of the most significant opportunities and challenges facing healthcare today at the DIA-MHRA Global Summit.
The stepwise implementation programme aims to deliver the first wave 1 regulatory assessment in 14 calendar days for qualifying applications by the end of 2026.
Introduction At the end of March 2026, we launched the MHRA 14-day…
This guidance summarises our approach to pharmacovigilance
HRA transactions over £500 made using the government procurement card (GPC).
Relevant safety information for users of magnetic resonance imaging (MRI) equipment in clinical use.
A national programme to help drive advancements in healthcare, to ensure patients benefit from innovation and new treatments sooner.
List of Field Safety Notices from 21 to 25 September 2026.
Summary of the latest safety advice for medicines and medical device users
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).